Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1–98
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1–98 ; volume:21 ; number:1 ; day:22 ; month:2 ; year:2019 ; pages:1-11 ; date:12.2019
Breast cancer research ; 21, Heft 1 (22.2.2019), 1-11, 12.2019
- Urheber
-
Kensler, Kevin H.
Regan, Meredith M.
Heng, Yujing J.
Baker, Gabrielle M.
Pyle, Michael E.
Schnitt, Stuart J.
Hazra, Aditi
Kammler, Roswitha
Thürlimann, Beat
Colleoni, Marco
Viale, Giuseppe
Brown, Myles
Tamimi, Rulla M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13058-019-1118-z
- URN
-
urn:nbn:de:101:1-2019032023311442787328
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kensler, Kevin H.
- Regan, Meredith M.
- Heng, Yujing J.
- Baker, Gabrielle M.
- Pyle, Michael E.
- Schnitt, Stuart J.
- Hazra, Aditi
- Kammler, Roswitha
- Thürlimann, Beat
- Colleoni, Marco
- Viale, Giuseppe
- Brown, Myles
- Tamimi, Rulla M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination
ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
SPDEF Regulates Fatty Acid Metabolism Driving Tumor Growth in Androgen Receptor-Positive Breast Cancer
Rat Models of Hormone Receptor-Positive Breast Cancer
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
Patients’ preferences for postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treatments in Japan
Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case–cohort analysis
Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination
ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
SPDEF Regulates Fatty Acid Metabolism Driving Tumor Growth in Androgen Receptor-Positive Breast Cancer
Rat Models of Hormone Receptor-Positive Breast Cancer
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
Patients’ preferences for postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treatments in Japan
Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case–cohort analysis
Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination
ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
SPDEF Regulates Fatty Acid Metabolism Driving Tumor Growth in Androgen Receptor-Positive Breast Cancer
Rat Models of Hormone Receptor-Positive Breast Cancer
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer
Patients’ preferences for postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treatments in Japan
Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case–cohort analysis
Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy